Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) saw a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 2 shares, a decline of 99.5% from the October 15th total of 423 shares. Based on an average daily trading volume, of 457 shares, the days-to-cover ratio is currently 0.0 days.
Hikma Pharmaceuticals Price Performance
HKMPY remained flat at $47.75 on Tuesday. Hikma Pharmaceuticals has a 52-week low of $31.80 and a 52-week high of $47.75. The stock’s fifty day moving average price is $43.57 and its 200 day moving average price is $40.76.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals plc is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Its portfolio includes generic, branded and specialty pharmaceutical products, as well as injectable medicines used in hospitals and other healthcare settings. The company serves healthcare providers, pharmacies and patients across the United States, Europe, the Middle East and North Africa, and other international markets. Its products cover a variety of therapeutic areas, with operations spanning prescription medicines, hospital injectables and established branded treatments.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
